These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 1342678

  • 21. Serotonin receptors: subtypes, functional responses and therapeutic relevance.
    Saxena PR.
    Pharmacol Ther; 1995 May; 66(2):339-68. PubMed ID: 7667401
    [Abstract] [Full Text] [Related]

  • 22. [Serotonin and treatment of mental disorders. Present status and future perspectives].
    Sevcík J, Masek K.
    Cas Lek Cesk; 1997 Jul 14; 136(14):431-3. PubMed ID: 9340186
    [Abstract] [Full Text] [Related]

  • 23. Contribution of serotonin neurotoxins to understanding psychiatric disorders: the role of 5-HT2 receptors in schizophrenia and antipsychotic activity.
    Schmidt CJ, Kehne JH, Carr AA, Fadayel GM, Humphreys TM, Kettler HJ, McCloskey TC, Padich RA, Taylor VL, Sorensen SM.
    Int Clin Psychopharmacol; 1993 Nov 14; 8 Suppl 2():25-32. PubMed ID: 7911139
    [No Abstract] [Full Text] [Related]

  • 24. The antidepressant effects of 5-HT uptake inhibitors.
    Aberg-Wistedt A.
    Br J Psychiatry Suppl; 1989 Dec 14; (8):32-40. PubMed ID: 2692638
    [Abstract] [Full Text] [Related]

  • 25. Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists.
    Holsboer F, Ising M.
    Eur J Pharmacol; 2008 Apr 07; 583(2-3):350-7. PubMed ID: 18272149
    [Abstract] [Full Text] [Related]

  • 26. Therapeutic potential of serotonin antagonists in depressive disorders.
    Wood MD, Thomas DR, Watson JM.
    Expert Opin Investig Drugs; 2002 Apr 07; 11(4):457-67. PubMed ID: 11922855
    [Abstract] [Full Text] [Related]

  • 27. [Serotonin receptor subtypes. Considerations on their physiological role and therapeutic prospects].
    Di Renzo G, Marino A.
    Clin Ter; 1990 Apr 15; 133(1):3-7. PubMed ID: 2140742
    [Abstract] [Full Text] [Related]

  • 28. Serotonin S2 receptors blockage and generalized anxiety disorders. A double-blind study on ritanserin and lorazepam.
    Bressa GM, Marini S, Gregori S.
    Int J Clin Pharmacol Res; 1987 Apr 15; 7(2):111-9. PubMed ID: 3108171
    [Abstract] [Full Text] [Related]

  • 29. Neuropeptides: relevance in treatment of depression and anxiety disorders.
    Madaan V, Wilson DR.
    Drug News Perspect; 2009 Apr 15; 22(6):319-24. PubMed ID: 19771321
    [Abstract] [Full Text] [Related]

  • 30. Serotonin: la chica de moda in biological psychiatry?
    Banki CM.
    Biol Psychiatry; 1991 May 15; 29(10):949-52. PubMed ID: 2065139
    [No Abstract] [Full Text] [Related]

  • 31. [Behavior of 5-HT receptors during long-term antidepressant treatment and at discontinuation].
    Fillion G.
    Encephale; 1995 Feb 15; 21 Spec No 1():3-6. PubMed ID: 7729352
    [No Abstract] [Full Text] [Related]

  • 32. The role of serotonin in depression and anxiety.
    Baldwin D, Rudge S.
    Int Clin Psychopharmacol; 1995 Jan 15; 9 Suppl 4():41-5. PubMed ID: 7622823
    [Abstract] [Full Text] [Related]

  • 33. Neurobiological mechanisms in generalized anxiety disorder.
    Nutt DJ.
    J Clin Psychiatry; 2001 Jan 15; 62 Suppl 11():22-7; discussion 28. PubMed ID: 11414547
    [Abstract] [Full Text] [Related]

  • 34. The serotonin-7 receptor as a novel therapeutic target.
    Stahl SM.
    J Clin Psychiatry; 2010 Nov 15; 71(11):1414-5. PubMed ID: 21114946
    [Abstract] [Full Text] [Related]

  • 35. Receptor alterations associated with serotonergic agents: an autoradiographic analysis.
    Wamsley JK, Byerley WF, McCabe RT, McConnell EJ, Dawson TM, Grosser BI.
    J Clin Psychiatry; 1987 Mar 15; 48 Suppl():19-25. PubMed ID: 3029045
    [Abstract] [Full Text] [Related]

  • 36. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL, Pigott TA.
    J Clin Psychiatry; 1990 Apr 15; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [Abstract] [Full Text] [Related]

  • 37. 5-HT2C receptor agonists as an innovative approach for psychiatric disorders.
    Rosenzweig-Lipson S, Dunlop J, Marquis KL.
    Drug News Perspect; 2007 Nov 15; 20(9):565-71. PubMed ID: 18176661
    [Abstract] [Full Text] [Related]

  • 38. Pharmacology of serotonin uptake inhibitors: focus on fluvoxamine.
    Hrdina PD.
    J Psychiatry Neurosci; 1991 Jul 15; 16(2 Suppl 1):10-8. PubMed ID: 1931931
    [No Abstract] [Full Text] [Related]

  • 39. Depression and 5HT.
    Deakin JF.
    Int Clin Psychopharmacol; 1991 Dec 15; 6 Suppl 3():23-8; discussion 29-31. PubMed ID: 1806632
    [Abstract] [Full Text] [Related]

  • 40. L-5-hydroxytryptophan in depression and anxiety.
    van Praag HM, Kahn RS.
    Schweiz Rundsch Med Prax; 1988 Aug 23; 77(34A):40-6. PubMed ID: 3055148
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.